Results 351 to 360 of about 275,584 (397)
Some of the next articles are maybe not open access.

Related searches:

Treg cells in autoimmunity: from identification to Treg-based therapies

Seminars in Immunopathology, 2019
Regulatory (Treg) cells are key regulators of inflammation and important for immune tolerance and homeostasis. A major progress has been made in the identification and classification of Treg cells. Due to technological advances, we have gained deep insights in the epigenetic regulation of Treg cells. The use of fate reporter mice allowed addressing the
L. Göschl, C. Scheinecker, M. Bonelli
semanticscholar   +3 more sources

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

open access: yesNature Medicine, 2022
Jay Y Spiegel   +2 more
exaly   +2 more sources

Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion

open access: yesNature Immunology, 2019
Regulatory T cells (Treg cells) maintain host self-tolerance but are a major barrier to effective cancer immunotherapy. Treg cells subvert beneficial anti-tumor immunity by modulating inhibitory receptor expression on tumor-infiltrating lymphocytes (TILs)
Deepali V Sawant   +2 more
exaly   +2 more sources

Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

open access: yesCancer Science, 2019
Regulatory T (Treg) cells suppress abnormal/excessive immune responses to self‐ and nonself‐antigens to maintain immune homeostasis. In tumor immunity, Treg cells are involved in tumor development and progression by inhibiting antitumor immunity.
Yoshihiro Ohue, Hiroyoshi Nishikawa
exaly   +2 more sources

When worlds collide: Th17 and Treg cells in cancer and autoimmunity

open access: yesCellular and Molecular Immunology, 2018
Hannah M Knochelmann   +2 more
exaly   +2 more sources

Treg cells in atherosclerosis

Molecular Biology Reports, 2021
Atherosclerosis involves both innate and adaptive immunity. Here, we provide an overview of the role of regulatory T (Treg) cells in atherosclerotic diseases. Treg cells and their inhibitory cytokines, IL-10 and TGF-β, have been identified in atherosclerotic lesions and to inhibit progression through lipoprotein metabolism modulation.
Rebecca Kuan   +2 more
openaire   +2 more sources

CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity

open access: yesNature Cancer, 2020
Intratumoral regulatory T (Treg) cell abundance associates with diminished antitumor immunity and poor prognosis in human cancers. Recent work demonstrates that CD25, the high-affinity receptor subunit for interleukin (IL)-2, is a selective target for ...
Ehsan Ghorani   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy